Mobile Application to Promote Adherence to Oral Chemotherapy and Symptom Management: A Protocol for Design and Development

Joel Nathan Fishbein, Lauren Ellen Nisotel, James John MacDonald, Nicole Amoyal Pensak, Jamie Michele Jacobs, Clare Flanagan, Kamal Jethwani, Joseph Andrew Greer, Joel Nathan Fishbein, Lauren Ellen Nisotel, James John MacDonald, Nicole Amoyal Pensak, Jamie Michele Jacobs, Clare Flanagan, Kamal Jethwani, Joseph Andrew Greer

Abstract

Background: Oral chemotherapy is increasingly used in place of traditional intravenous chemotherapy to treat patients with cancer. While oral chemotherapy includes benefits such as ease of administration, convenience, and minimization of invasive infusions, patients receive less oversight, support, and symptom monitoring from clinicians. Additionally, adherence is a well-documented challenge for patients with cancer prescribed oral chemotherapy regimens. With the ever-growing presence of smartphones and potential for efficacious behavioral intervention technology, we created a mobile health intervention for medication and symptom management.

Objective: The objective of this study was to develop and evaluate the usability and acceptability of a smartphone app to support adherence to oral chemotherapy and symptom management in patients with cancer.

Methods: We used a 5-step development model to create a comprehensive mobile app with theoretically informed content. The research and technical development team worked together to develop and iteratively test the app. In addition to the research team, key stakeholders including patients and family members, oncology clinicians, health care representatives, and practice administrators contributed to the content refinement of the intervention. Patient and family members also participated in alpha and beta testing of the final prototype to assess usability and acceptability before we began the randomized controlled trial.

Results: We incorporated app components based on the stakeholder feedback we received in focus groups and alpha and beta testing. App components included medication reminders, self-reporting of medication adherence and symptoms, an education library including nutritional information, Fitbit integration, social networking resources, and individually tailored symptom management feedback. We are conducting a randomized controlled trial to determine the effectiveness of the app in improving adherence to oral chemotherapy, quality of life, and burden of symptoms and side effects. At every stage in this trial, we are engaging stakeholders to solicit feedback on our progress and next steps.

Conclusions: To our knowledge, we are the first to describe the development of an app designed for people taking oral chemotherapy. The app addresses many concerns with oral chemotherapy, such as medication adherence and symptom management. Soliciting feedback from stakeholders with broad perspectives and expertise ensured that the app was acceptable and potentially beneficial for patients, caregivers, and clinicians. In our development process, we instantiated 7 of the 8 best practices proposed in a recent review of mobile health app development. Our process demonstrated the importance of effective communication between research groups and technical teams, as well as meticulous planning of technical specifications before development begins. Future efforts should consider incorporating other proven strategies in software, such as gamification, to bolster the impact of mobile health apps. Forthcoming results from our randomized controlled trial will provide key data on the effectiveness of this app in improving medication adherence and symptom management.

Trial registration: ClinicalTrials.gov NCT02157519; https://ichgcp.net/clinical-trials-registry/NCT02157519 (Archived by WebCite at http://www.webcitation.org/6prj3xfKA).

Keywords: ambulatory monitoring; antineoplastic agents; mHealth; medication adherence; mobile apps; neoplasms; self-administration; software design; telemedicine.

Conflict of interest statement

Conflicts of Interest: None declared.

©Joel Nathan Fishbein, Lauren Ellen Nisotel, James John MacDonald, Nicole Amoyal Pensak, Jamie Michele Jacobs, Clare Flanagan, Kamal Jethwani, Joseph Andrew Greer. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 20.04.2017.

Figures

Figure 1
Figure 1
Wireframes for Chemotherapy Assistant mobile app.

References

    1. Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM, Langbaum TS, Leedy RD, Muller RJ, Newcomer LN, O'Brien S, Reinke D, Rubino M, Saltz L, Walters RS. NCCN Task Force Report: Oral chemotherapy. J Natl Compr Canc Netw. 2008 Mar;6 Suppl 3:S1–S14.
    1. Liu G, Franssen E, Fitch MI, Warner E. Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol. 1997 Jan;15(1):110–115.
    1. Paley M, Love N, Carlson R, Tripathy D, Kaderman R, Dvorkin J, Ziel K. Preferences for oral and parenteral antitumor therapy: a survey of 260 patients with metastatic breast cancer. J Clin Oncol (Meeting Abstracts) 2005:619. doi: 10.1200/jco.2005.23.16_suppl.619.
    1. Payne SA. A study of quality of life in cancer patients receiving palliative chemotherapy. Soc Sci Med. 1992 Dec;35(12):1505–1509.
    1. Borner MM, Schoffski P, de Wit R, Caponigro F, Comella G, Sulkes A, Greim G, Peters GJ, van der Born K, Wanders J, de Boer RF, Martin C, Fumoleau P. Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer. 2002 Feb;38(3):349–358.
    1. Banna GL, Collovà E, Gebbia V, Lipari H, Giuffrida P, Cavallaro S, Condorelli R, Buscarino C, Tralongo P, Ferraù F. Anticancer oral therapy: emerging related issues. Cancer Treat Rev. 2010 Dec;36(8):595–605. doi: 10.1016/j.ctrv.2010.04.005.
    1. Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002 May 1;94(9):652–661.
    1. Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009;59(1):56–66. doi: 10.3322/caac.20004. doi: 10.3322/caac.20004.
    1. Escalada P, Griffiths P. Do people with cancer comply with oral chemotherapy treatments? Br J Community Nurs. 2006 Dec;11(12):532–536. doi: 10.12968/bjcn.2006.11.12.22424.
    1. Wood L. A review on adherence management in patients on oral cancer therapies. Eur J Oncol Nurs. 2012 Sep;16(4):432–438. doi: 10.1016/j.ejon.2011.10.002.
    1. Greer JA, Amoyal N, Nisotel L, Fishbein JN, MacDonald J, Stagl J, Lennes I, Temel JS, Safren SA, Pirl WF. A systematic review of adherence to oral antineoplastic therapies. Oncologist. 2016 Mar;21(3):354–376. doi: 10.1634/theoncologist.2015-0405.
    1. Steinhubl SR, Muse ED, Topol EJ. Can mobile health technologies transform health care? JAMA. 2013 Dec 11;310(22):2395–2396. doi: 10.1001/jama.2013.281078.
    1. Heron KE, Smyth JM. Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments. Br J Health Psychol. 2010 Feb;15(Pt 1):1–39. doi: 10.1348/135910709X466063.
    1. Simoni JM, Huh D, Frick PA, Pearson CR, Andrasik MP, Dunbar PJ, Hooton TM. Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial. J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):465–473.
    1. DeKoekkoek T, Given B, Given CW, Ridenour K, Schueller M, Spoelstra SL. mHealth SMS text messaging interventions and to promote medication adherence: an integrative review. J Clin Nurs. 2015 Oct;24(19-20):2722–2735. doi: 10.1111/jocn.12918.
    1. Darlow S, Wen K. Development testing of mobile health interventions for cancer patient self-management: A review. Health Informatics J. 2015 Apr 27;:1–18. doi: 10.1177/1460458215577994.
    1. Ernst LL, Harden CL, Pennell PB, Llewellyn N, Lau C, Barnard S, Bartfeld E, French JA. Medication adherence in women with epilepsy who are planning pregnancy. Epilepsia. 2016 Oct 25; doi: 10.1111/epi.13586.
    1. Kreyenbuhl J, Record EJ, Himelhoch S, Charlotte M, Palmer-Bacon J, Dixon LB, Medoff DR, Li L. Development and feasibility testing of a smartphone intervention to improve adherence to antipsychotic medications. Clin Schizophr Relat Psychoses. 2016 Jul 25; doi: 10.3371/CSRP.KRRE.070816.
    1. Lakshminarayana R, Wang D, Burn D, Chaudhuri KR, Cummins G, Galtrey C, Hellman B, Pal S, Stamford J, Steiger M, Williams A, The SMART-PD Investigators Smartphone- and Internet-assisted self-management and adherence tools to manage Parkinson's disease (SMART-PD): study protocol for a randomised controlled trial. Trials. 2014;15:374. doi: 10.1186/1745-6215-15-374.
    1. Patel S, Jacobus-Kantor L, Marshall L, Ritchie C, Kaplinski M, Khurana PS, Katz RJ. Mobilizing your medications: an automated medication reminder application for mobile phones and hypertension medication adherence in a high-risk urban population. J Diabetes Sci Technol. 2013 May 01;7(3):630–639.
    1. Perera AI, Thomas MG, Moore JO, Faasse K, Petrie KJ. Effect of a smartphone application incorporating personalized health-related imagery on adherence to antiretroviral therapy: a randomized clinical trial. AIDS Patient Care STDS. 2014 Nov;28(11):579–586. doi: 10.1089/apc.2014.0156.
    1. Sarzynski E, Decker B, Thul A, Weismantel D, Melaragni R, Cholakis E, Tewari M, Beckholt K, Zaroukian M, Kennedy AC, Given C. Beta testing a novel smartphone application to improve medication adherence. Telemed J E Health. 2016 Aug 26; doi: 10.1089/tmj.2016.0100.
    1. Mohr DC, Schueller SM, Montague E, Burns MN, Rashidi P. The behavioral intervention technology model: an integrated conceptual and technological framework for eHealth and mHealth interventions. J Med Internet Res. 2014;16(6):e146. doi: 10.2196/jmir.3077.
    1. Whittaker R, Merry S, Dorey E, Maddison R. A development and evaluation process for mHealth interventions: examples from New Zealand. J Health Commun. 2012;17 Suppl 1:11–21. doi: 10.1080/10810730.2011.649103.
    1. Murray MD, Morrow DG, Weiner M, Clark DO, Tu W, Deer MM, Brater DC, Weinberger M. A conceptual framework to study medication adherence in older adults. Am J Geriatr Pharmacother. 2004 Mar;2(1):36–43.
    1. Highland J, Clemens H, Loren L, Roberts J. Actuarial assessment of Senate Bill 1070: An Act Relative to Oral Cancer Therapy. 2012. Jun, [2016-03-04]. .
    1. Borner MM, Dietrich D, Stupp R, Morant R, Honegger H, Wernli M, Herrmann R, Pestalozzi BC, Saletti P, Hanselmann S, Müller S, Brauchli P, Castiglione-Gertsch M, Goldhirsch A, Roth AD. Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer. J Clin Oncol. 2002 Apr 1;20(7):1759–1766.
    1. O'Neill VJ, Twelves CJ. Oral cancer treatment: developments in chemotherapy and beyond. Br J Cancer. 2002 Oct 21;87(9):933–937. doi: 10.1038/sj.bjc.6600591. doi: 10.1038/sj.bjc.6600591.
    1. Mirkovic J, Kaufman DR, Ruland CM. Supporting cancer patients in illness management: usability evaluation of a mobile app. JMIR Mhealth Uhealth. 2014;2(3):e33. doi: 10.2196/mhealth.3359.
    1. Glasgow RE, Kaplan RM, Ockene JK, Fisher EB, Emmons KM. Patient-reported measures of psychosocial issues and health behavior should be added to electronic health records. Health Aff (Millwood) 2012 Mar;31(3):497–504. doi: 10.1377/hlthaff.2010.1295.
    1. Wu AW, Kharrazi H, Boulware LE, Snyder CF. Measure once, cut twice—adding patient-reported outcome measures to the electronic health record for comparative effectiveness research. J Clin Epidemiol. 2013 Aug;66(8 Suppl):S12–S20. doi: 10.1016/j.jclinepi.2013.04.005.
    1. Partridge AH, Seah DSE, King T, Leighl NB, Hauke R, Wollins DS, Von Roenn JH. Developing a service model that integrates palliative care throughout cancer care: the time is now. J Clin Oncol. 2014 Oct 10;32(29):3330–3336. doi: 10.1200/JCO.2013.54.8149.
    1. Smith TG, Castro KM, Troeschel AN, Arora NK, Lipscomb J, Jones SM, Treiman KA, Hobbs C, McCabe RM, Clauser SB. The rationale for patient-reported outcomes surveillance in cancer and a reproducible method for achieving it. Cancer. 2016 Feb 01;122(3):344–351. doi: 10.1002/cncr.29767.
    1. Maguire R, Ream E, Richardson A, Connaghan J, Johnston B, Kotronoulas G, Pedersen V, McPhelim J, Pattison N, Smith A, Webster L, Taylor A, Kearney N. Development of a novel remote patient monitoring system: the advanced symptom management system for radiotherapy to improve the symptom experience of patients with lung cancer receiving radiotherapy. Cancer Nurs. 2015;38(2):E37–E47. doi: 10.1097/NCC.0000000000000150.
    1. Yap KY, Low HX, Koh KS, Un M, Shih V, Chan A. Feasibility and acceptance of a pharmacist-run tele-oncology service for chemotherapy-induced nausea and vomiting in ambulatory cancer patients. Telemed J E Health. 2013 May;19(5):387–395. doi: 10.1089/tmj.2012.0136.
    1. Kearney N, Kidd L, Miller M, Sage M, Khorrami J, McGee M, Cassidy J, Niven K, Gray P. Utilising handheld computers to monitor and support patients receiving chemotherapy: results of a UK-based feasibility study. Support Care Cancer. 2006 Jul;14(7):742–752. doi: 10.1007/s00520-005-0002-9.
    1. Weaver A, Young AM, Rowntree J, Townsend N, Pearson S, Smith J, Gibson O, Cobern W, Larsen M, Tarassenko L. Application of mobile phone technology for managing chemotherapy-associated side-effects. Ann Oncol. 2007 Nov;18(11):1887–1892. doi: 10.1093/annonc/mdm354.
    1. McGee M, Gray P. A handheld chemotherapy symptom management system: results from a preliminary outpatient field trial. Health Informatics J. 2005;11(4):243–258.
    1. Shiffman S, Stone AA, Hufford MR. Ecological momentary assessment. Annu Rev Clin Psychol. 2008;4:1–32.
    1. Stone AA, Shiffman S. Ecological momentary assessment (EMA) in behavioral medicine. Ann Behav Med. 1994;16(3):199–202.
    1. Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, Aikens JE, Hunter CM, Velligan DI, Huntley K, Ogedegbe G, Rand CS, Schron E, Nilsen WJ. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015 Dec;5(4):470–482. doi: 10.1007/s13142-015-0315-2.
    1. Eysenbach G. CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet Res. 2011;13(4):e126. doi: 10.2196/jmir.1923.
    1. Frank L, Basch E, Selby JV, Patient-Centered Outcomes Research Institute The PCORI perspective on patient-centered outcomes research. JAMA. 2014 Oct 15;312(15):1513–1514. doi: 10.1001/jama.2014.11100.
    1. Deterding S, Dixon D, Khaled R, Nacke L. From game design elements to gamefulness: defining gamification. Proceedings of the 15th International Academic MindTrek Conference: Envisioning Future Media Environments; 2011; Tampere. 2011.
    1. Miller AS, Cafazzo JA, Seto E. A game plan: gamification design principles in mHealth applications for chronic disease management. Health Informatics J. 2014 Jul 1;:184–193. doi: 10.1177/1460458214537511.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren